Los Angeles, California, United States
CFO-track finance executive with 30 years leading financial strategy, FP&A, business transformation, and P&L ownership at scale. Currently Division Vice President, Finance & Controller at Abbott — a $40B global Life Science leader — with responsibility for the Cardiac Rhythm Management division across planning, reporting, and strategic finance. Prior senior finance leadership at Marriott International, Pfizer, and Deloitte. Proven across medical devices, pharmaceuticals, hospitality, and technology — with particular depth in MedTech business partnering, M&A integration, capital allocation, and operating model transformation. Los Angeles-based. Open to CFO and senior finance leadership opportunities in MedTech, healthcare, and high-growth industries. ── CAREER HIGHLIGHTS ── ▸ Business Turnaround | Abbott CRM Architected and executed the divisional financial strategy to reverse a multi-year revenue decline — driving growth at 3x the market rate in a low-growth cardiac device segment through rigorous FP&A, commercial finance partnering, and operating model restructuring. ▸ M&A Integration | St. Jude Medical Acquisition Led global operations finance integration post-acquisition, delivering $250MM in margin expansion and achieving multi-year synergy targets ahead of schedule. ▸ Capital Strategy | Marriott International Secured board approval for $3B+ in revenue-generating capital investments — leading financial modelling, scenario planning, and executive presentation of multi-property capital programs. ▸ Profitability Turnaround | Marriott Spearheaded the financial turnaround of an underperforming $400M property portfolio, delivering a $60MM profitability improvement through operational restructuring and financial control.
Division VP Finance and Controller for Abbott's Cardiac Rhythm Management (CRM) business — a multi-billion dollar medical device division within a $40B global healthcare leader. Full P&L ownership spanning financial planning & analysis (FP&A), strategic finance, management reporting, financial close, capital allocation, SOX compliance, and executive business partnering across commercial, R&D, and manufacturing functions. Accountable for divisional operating plan (AOP), long-range planning, and finance leadership for a portfolio of cardiac rhythm and electrophysiology device programs in a highly regulated MedTech environment. ▸ Business Turnaround | CRM Division Architected and executed the divisional financial strategy to reverse a multi-year revenue decline — driving growth at 3x the market rate in a low-growth cardiac device segment through rigorous FP&A, commercial finance partnering, and operating model restructuring. ▸ Finance Function Transformation Built a forward-looking, analytics-driven finance function — integrating AI-enabled forecasting and planning tools to reduce cycle time, improve forecast accuracy, and elevate financial decision-making. ▸ Executive & Board Reporting Designed divisional financial reporting frameworks for senior leadership and corporate board consumption — translating complex operational data into clear strategic narratives. FP&A · Controller · P&L Management · Strategic Finance · Capital Allocation · SOX Compliance · Medical Device Finance · Cardiac Rhythm Management · AOP · Financial Close · Business Partnering · GAAP · MedTech
Senior finance leadership role accountable for global operations finance across Abbott's Cardiovascular and Neuromodulation divisions following the $25B acquisition of St. Jude Medical — one of the largest M&A transactions in MedTech history. Led end-to-end financial integration across a $2B+ combined global operations footprint spanning manufacturing, supply chain, and R&D — accountable for integration financial governance, cost synergy tracking, and cross-divisional reporting. ▸ M&A Integration — St. Jude Medical Delivered $250MM in margin expansion and achieved multi-year cost synergy targets through disciplined integration financial management, zero-based budgeting, and operational restructuring across combined manufacturing and supply chain networks. ▸ Global Operations Finance Established unified FP&A, reporting, and financial control frameworks across the combined CV&N divisions — enabling leadership visibility and accelerating post-merger performance management. M&A Integration · Post-Merger Integration · Global Operations Finance · FP&A · Cost Synergy · SOX Compliance · Medical Device Finance · MedTech · Supply Chain Finance · Strategic Finance
Global Operations Controller for Abbott Vascular — a leading cardiovascular device business with a multi-billion dollar global manufacturing and supply chain footprint. Accountable for financial control, FP&A, cost management, and SOX compliance across global manufacturing sites in the US, Ireland, and Switzerland. ▸ Cost Transformation Delivered an average of $50MM in annual cost savings through manufacturing efficiency programs, zero-based budgeting, and supply chain financial optimisation across a complex global network. ▸ Financial Control & Compliance Eliminated $20MM+ in financial exposure through strengthened SOX compliance frameworks, internal control enhancements, and risk-based financial governance across multi-site global operations. Global Operations Finance · Controller · Manufacturing Finance · Cost Management · SOX Compliance · FP&A · Medical Device Finance · Cardiovascular Devices · GAAP · IFRS · Abbott Vascular
Senior finance leadership role within Marriott Vacations Worldwide — accountable for asset financial performance, capital strategy, and long-range financial planning across a multi-billion dollar managed and franchised property portfolio. ▸ Capital Strategy & Board Approval Led financial modelling, scenario analysis, and board-level approval of $3B+ in revenue-generating capital investments — spanning renovation programs, repositioning strategies, and new development. ▸ Profitability Turnaround Spearheaded the financial turnaround of an underperforming $400M property — delivering a $60MM profitability improvement through operational restructuring and revenue strategy realignment. Capital Strategy · Asset Management · FP&A · P&L Ownership · Financial Modelling · Board Presentations · Strategic Finance · Business Partnering · Hospitality Finance
Financial Controller for a greenfield $700MM+ Pfizer pharmaceutical manufacturing facility — accountable for standing up the full finance function from pre-operational phase through commercial launch. Responsibilities spanned financial control, FP&A, cost accounting, capital project oversight, and regulatory financial compliance in a highly regulated pharmaceutical manufacturing environment. Controller · Manufacturing Finance · FP&A · Capital Projects · Pharmaceutical Finance · GAAP · IFRS · Financial Control · Greenfield Operations